A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines

E-ISSN： 1875-6220|10|4|283-304

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.10, Iss.4, 2013-12, pp. : 283-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite

Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy

By Coluccia AML Gunby RH Tartari CJ Scapozza L Gambacorti-Passerini C Passoni Lorena

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 515-532

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines

By Kano Yasuhiko Akutsu Miyuki Tsunoda Saburo Izumi Tohru Kobayashi Hiroyuki Mano Hiroyuki Furukawa Yusuke

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 31-40

Springer Publishing Company

Access to resources Recommend Favorite

Novel therapeutic targets in mantle cell lymphoma

By Martin Peter Leonard John P

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 929-940

Informa Healthcare

Access to resources Recommend Favorite

Human Leukemia and Lymphoma Cell Lines as Models and Resources

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-01 ,pp. : 339-359

Bentham Science Publishers

Access to resources Recommend Favorite